SAN FRANCISCO, Jan. 9 - Myriad Proteomics in mid-January will begin trying to fulfill its pledge to map the human proteome within three years as researchers get set to move into the company's new facility, Peter Meldrum, CEO of Myriad Genetics, said on Wednesday.
Move-in day, Jan. 16, is when the three-year time clock starts ticking.
In April, Myriad joined with Hitachi and Oracle to start Myriad Proteomics. Since that time, Myriad Proteomics has designed, built, and furnished its facility Salt Lake City and hired a 50-person staff, Meldrum said. He spoke at the 20th annual JPMorgan H&Q Healthcare Conference here, which ends on Thursday.
Myriad Genetics has 50 percent ownership in the proteomics venture. "They will map the human proteome and we will get free access to the data," said Meldrum.